Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype

Prof Giovanni Martinelli - University of Bologna, Bologna, Italy
Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype ( Prof Giovanni Martinelli - University of Bologna, Bologna, Italy )
6 Dec 2015

Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia

Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia ( Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France )
6 Dec 2015

First all-oral treatment for relapsed and treatment-resistant multiple myeloma

Prof Philippe Moreau - University of Nantes, Nantes, France
First all-oral treatment for relapsed and treatment-resistant multiple myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
6 Dec 2015

Experimental oral therapy for high-risk CLL shows promise

Prof Stephan Stilgenbauer - University of Ulm, Ulm, Germany
Experimental oral therapy for high-risk CLL shows promise ( Prof Stephan Stilgenbauer - University of Ulm, Ulm, Germany )
6 Dec 2015

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia ( Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy )
6 Dec 2015

Idelalisib combination therapy in relapsed or treatment-resistant CLL better than standard regimen

Dr Andrew Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA
Idelalisib combination therapy in relapsed or treatment-resistant CLL better than standard regimen ( Dr Andrew Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Dec 2015

ASH 2015: Novel combination approaches for multiple myeloma

Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios Dimopoulos
ASH 2015: Novel combination approaches for multiple myeloma ( Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios Dimopoulos )
6 Dec 2015

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia

Prof John Gribben and Prof Stilgenbauer
ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia ( Prof John Gribben and Prof Stilgenbauer )
6 Dec 2015

ASH 2015: New targeted therapies for haematological malignancies

Dr Robert Hromas - University of Florida, Gainesville, USA
ASH 2015: New targeted therapies for haematological malignancies ( Dr Robert Hromas - University of Florida, Gainesville, USA )
6 Dec 2015

Using epigenetics to manipulate cancer cells

Dr Stephen Nimer - Sylvester Comprehensive Cancer, Miami, USA
Using epigenetics to manipulate cancer cells ( Dr Stephen Nimer - Sylvester Comprehensive Cancer, Miami, USA )
6 Dec 2015

Overcoming the barriers of the P53 dysfunction to cure blood cancers

Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA
Overcoming the barriers of the P53 dysfunction to cure blood cancers ( Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA )
6 Dec 2015

Exciting new immunosuppressive therapy treatment for aplastic anaemia

Dr Danielle Townsley - George Washington University School of Medicine, Washington, USA
Exciting new immunosuppressive therapy treatment for aplastic anaemia ( Dr Danielle Townsley - George Washington University School of Medicine, Washington, USA )
6 Dec 2015